tiprankstipranks
Trending News
More News >
CytoMed Therapeutics Limited (GDTC)
NASDAQ:GDTC
US Market
Advertisement

CytoMed Therapeutics Limited (GDTC) Price & Analysis

Compare
10 Followers

GDTC Stock Chart & Stats


CytoMed Therapeutics Limited News

GDTC FAQ

What was CytoMed Therapeutics Limited’s price range in the past 12 months?
CytoMed Therapeutics Limited lowest stock price was $1.20 and its highest was $4.05 in the past 12 months.
    What is CytoMed Therapeutics Limited’s market cap?
    CytoMed Therapeutics Limited’s market cap is $23.12M.
      When is CytoMed Therapeutics Limited’s upcoming earnings report date?
      CytoMed Therapeutics Limited’s upcoming earnings report date is Nov 14, 2025 which is in 77 days.
        How were CytoMed Therapeutics Limited’s earnings last quarter?
        Currently, no data Available
        Is CytoMed Therapeutics Limited overvalued?
        According to Wall Street analysts CytoMed Therapeutics Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does CytoMed Therapeutics Limited pay dividends?
          CytoMed Therapeutics Limited does not currently pay dividends.
          What is CytoMed Therapeutics Limited’s EPS estimate?
          CytoMed Therapeutics Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does CytoMed Therapeutics Limited have?
          CytoMed Therapeutics Limited has 11,733,712 shares outstanding.
            What happened to CytoMed Therapeutics Limited’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of CytoMed Therapeutics Limited?
            Currently, no hedge funds are holding shares in GDTC

            CytoMed Therapeutics Limited Stock Smart Score

            Company Description

            CytoMed Therapeutics Limited

            CytoMed Therapeutics Limited (GDTC) is a biotechnology company focused on the development and commercialization of innovative cell-based therapies for the treatment of various diseases. The company is engaged in research and development activities primarily in the field of regenerative medicine, using advanced cellular technologies to address unmet medical needs. CytoMed's core products include a pipeline of therapeutic candidates designed to harness the power of cellular therapy to restore health and improve patient outcomes.

            CytoMed Therapeutics Limited (GDTC) Earnings & Revenues

            Currently, no data available
            Please return soon. This page is being updated.
            Similar Stocks
            Company
            Price & Change
            Follow
            Tempest Therapeutics
            VYNE Therapeutics
            Clene
            PolyPid
            Barinthus Biotherapeutics

            Ownership Overview

            26.57%0.04%0.04%73.35%
            26.57% Insiders
            0.04% Other Institutional Investors
            73.35% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis